Albert F. LoBuglio

Medicine · Health Sciences

60h-index12.0kcitations307works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(66), Radiopharmaceutical Chemistry and Applications(49), Immunotherapy and Immune Responses(40), PARP inhibition in cancer therapy(38), Lymphoma Diagnosis and Treatment(33)

Publications307 total

Supplementary Table 1 from Effect of Niclosamide on Basal-like Breast Cancers
2023Open Access
Supplementary Figure 4 from Effect of Niclosamide on Basal-like Breast Cancers
2023Open Access
Data from Effect of Niclosamide on Basal-like Breast Cancers
2023Open Access
Supplementary Table 2 from Effect of Niclosamide on Basal-like Breast Cancers
2023Open Access
Supplemental Figures S1-S8 from Trastuzumab-Resistant HER2<sup>+</sup> Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition
2023Open Access
Supplementary Figure 4 from Effect of Niclosamide on Basal-like Breast Cancers
2023Open Access
Data from Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes
2023Open Access
Supplementary Figure 5 from Effect of Niclosamide on Basal-like Breast Cancers
2023Open Access
Supplementary Table 1 from Effect of Niclosamide on Basal-like Breast Cancers
2023Open Access
Supplementary Figure 3 from Effect of Niclosamide on Basal-like Breast Cancers
2023Open Access
Supplementary Figure 1 from Effect of Niclosamide on Basal-like Breast Cancers
2023Open Access
Supplemental Figures S1-S8 from Trastuzumab-Resistant HER2<sup>+</sup> Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition
2023Open Access
Supplemental Methods and Figure Legends from Trastuzumab-Resistant HER2<sup>+</sup> Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition
2023Open Access
Supplementary Figure 3 from Effect of Niclosamide on Basal-like Breast Cancers
2023Open Access
Data from Trastuzumab-Resistant HER2<sup>+</sup> Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition
2023Open Access
Supplementary Materials and Methods, Supplementary Figures 1 through 4, and Supplementary Tables 1 and 2 from Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes
2023Open Access
Data from Trastuzumab-Resistant HER2<sup>+</sup> Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition
2023Open Access
Data from Effect of Niclosamide on Basal-like Breast Cancers
2023Open Access
Supplementary Figure 5 from Effect of Niclosamide on Basal-like Breast Cancers
2023Open Access
Supplementary Materials and Methods, Supplementary Figures 1 through 4, and Supplementary Tables 1 and 2 from Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes
2023Open Access
page 1 of 16Next →

Frequent Co-authors

M.B. Khazaeli(13), William E. Grizzle(12), Mansoor N. Saleh(8), Ruby F. Meredith(7), Donald J. Buchsbaum(7), Jeffrey Schlom(7), Richard Wheeler(6), David T. Curiel(6), Susan E. Moore(6), Robert M. Conry(5), D L Barlow(5), R M Conry(4), L A Sumerel(4), Arthur L. Sagone(4), Ronald D. Alvarez(4), Edward E. Partridge(4), James A. Bonner(3), Delicia Carey(3), Harlan W. Waksal(3), Stanley P. Balcerzak(3)